What types of deceptive or unfair advertising actions are state AG offices initiating?
Since 2008, the States have brought and settled numerous actions for deceptive and unfair advertising violations – individually, as multi-states, and in coordination with the FTC. These include: • Off-label marketing – Multistate action against Eli Lilly for Zyprexa, led by Iowa AGO • Deceptive promotion & marketing – Multistate action against Pfizer, led by Oregon AGO • Deceptive advertising – Multistate action against Michelin, led by Kentucky AGO • Deceptive advertising – Joint action and settlement involving 35 states and the FTC against Lifelock In the wake of the recession, the States are particularly focused on debt management programs and healthcare marketing; they are also keeping an eye on retailer marketing practices, especially towards children, and have also submitted comments to the FTC on negative option marketing practices. Clearly, AG enforcement in this area is not limited to any one industry or type of advertising/marketing activity. Instead, state AG offices are loo
